It’s completely understandable to feel unsure before starting a biologic — especially when you’ve heard different experiences from different people.
Most patients with ABPA or severe Aspergillus-related asthma do very well on biologics. Side effects can happen, but they’re usually mild and settle quickly.
🌟 Most people report very few problems
Patients often say:
-
The injections are straightforward
-
They feel the same or better within days or weeks
-
There’s little or no impact on daily life
🌟 Common, mild side effects
These are the ones we hear most often across omalizumab, benralizumab, dupilumab and tezepelumab:
📌 Injection-site reactions
-
Redness
-
Itching
-
A small tender lump
-
Bruising
These usually disappear within 24–48 hours.
📌 Mild tiredness
Some people feel slightly “wiped out” after the first few doses.
📌 Headache
Very common with the first injection. Less so afterwards.
📌 Minor joint or muscle aches
A bit like the feeling after a flu jab.
📌 Nasal or sinus changes
Occasional mild dryness or congestion, especially with dupilumab.
🌟 Less common (still mild)
-
Mild tummy upset
-
Sore throat
-
A brief “flu-ish” feeling
-
Temporary increase in eczema (mainly with dupilumab)
-
Slight mood dip for a day or two (rare)
🌟 Rare but important
These are very uncommon, and your team will explain what to look out for:
-
Allergic reaction shortly after an injection
(This is why your first dose is supervised.) -
Eye inflammation — mostly linked to dupilumab, usually mild and treatable
Your team will give you clear advice on what to do if anything unusual happens.
🌟 What ABPA patients often notice
People with ABPA frequently describe:
👉 Fewer allergic symptoms
👉 Clearer breathing
👉 Much less mucus
👉 Fewer flare-ups and fewer steroids
But biologics don’t help everyone — which is why the first few months are monitored closely.
🌟 Final reassurance
For many aspergillosis patients, biologics are far easier than long-term steroids or antifungals. Most say the benefits outweigh the side effects — but every person’s experience is individual.
Share this post
Latest News posts
🔬 Charcot–Leyden Crystals in ABPA and Asthma
February 13, 2026
Event: 📸 Science is Open: A Photo Journey of Research Lab Samples
February 12, 2026
How to Join Our Microsoft Teams Meetings – Troubleshooting
February 12, 2026
Health effects: why aspergillosis patients are higher-risk
February 10, 2026
Damp, mould and aspergillosis in rented homes (UK)
February 10, 2026
Recognising a damp or mouldy home
February 10, 2026
Your rights, the law, and UK support organisations
February 10, 2026
Remediation, verification, and refusal to move you
February 10, 2026
How to raise damp and mould with your landlord (and get action)
February 10, 2026
News archive
- ABPA
- Air Quality
- Airway Clearance, Diagnosis & Physiotherapy
- Antifungals
- Aspergilloma
- Aspergillus Bronchitis
- Biologics
- Blood Tests
- CPA
- Carers & Family
- Communities
- Complementary & Supplements
- Complications
- Conditions
- Diagnostics
- Environment
- Events & Recordings
- GP Guidance
- General interest
- Housing & Damp
- Imaging
- Immune System
- Lifestyle & Coping
- Living with Aspergillosis
- Mental Health
- Monitoring
- Monitoring & Safety
- NAC & Guidance
- NAC Announcements
- Other
- Other Forms Aspergillosis
- Patient Research
- Pets & Animals
- Professional Guidance
- Recordings
- Research
- Research Summaries
- SAFS / Severe Asthma
- Side Effects
- Specialists
- Steroids
- Symptoms
- Travel and Insurance
- Treatment
- Vaccines
- Weekly Updates
